These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15506464)

  • 1. [Physiological and pathophysiological roles of the endothelin converting enzymes].
    Emoto N
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():636-9. PubMed ID: 15506464
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prospects for endothelin-related drugs].
    Goto K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():673-81. PubMed ID: 15506472
    [No Abstract]   [Full Text] [Related]  

  • 3. [Endothelin and kidney disease].
    Nakayama Y; Tomita K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():655-60. PubMed ID: 15506468
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats.
    Battistini B; Ayach B; Molez S; Blouin A; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():363S-366S. PubMed ID: 12193123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Involvement of endothelin in the pathogenesis of hypertension and hypertensive target-organ damage].
    Kanno K; Hirata Y
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():164-8. PubMed ID: 15171363
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained improvement of cardiac function and prevention of cardiac remodeling after long-term dual ECE-NEP inhibition in rats with congestive heart failure.
    Mulder P; Barbier S; Monteil C; Jeng AY; Henry JP; Renet S; Thuillez C
    J Cardiovasc Pharmacol; 2004 Apr; 43(4):489-94. PubMed ID: 15085059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biosynthetic mechanism of endothelins with various physiological and physiopathological significance--structure and function of endothelin converting enzyme].
    Takayanagi R
    Fukuoka Igaku Zasshi; 1995 Sep; 86(9):362-6. PubMed ID: 8522271
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of endothelin-converting enzyme, chymase and neutral endopeptidase in the processing of big ET-1, ET-1(1-21) and ET-1(1-31) in the trachea of allergic mice.
    De Campo BA; Goldie RG; Jeng AY; Henry PJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():353S-356S. PubMed ID: 12193121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelins are potent vasoconstrictors, and much more besides.
    Gray GA; Battistini B; Webb DJ
    Trends Pharmacol Sci; 2000 Feb; 21(2):38-40. PubMed ID: 10733432
    [No Abstract]   [Full Text] [Related]  

  • 10. SLV-306. Solvay.
    Tabrizchi R
    Curr Opin Investig Drugs; 2003 Mar; 4(3):329-32. PubMed ID: 12735234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.
    Daull P; Benrezzak O; Arsenault D; Pheng LH; Blouin A; Cayer J; Beaudoin M; Belleville K; Sirois P; Nantel F; Jeng AY; Battistini B
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1606-13. PubMed ID: 16364833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme.
    Woods M; Mitchell JA; Wood EG; Barker S; Walcot NR; Rees GM; Warner TD
    Mol Pharmacol; 1999 May; 55(5):902-9. PubMed ID: 10220569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective upregulation of endothelin converting enzyme-1a in the human failing heart.
    Ergul A; Grubbs AL; Zhang Y; Spinale FG
    J Card Fail; 2000 Dec; 6(4):314-20. PubMed ID: 11145756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene, molecular structure, and biosynthesis of the endothelin system].
    Emoto N
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():584-7. PubMed ID: 15506452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trend of research and development of antihypertensive agents].
    Imura Y
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():583-7. PubMed ID: 16895229
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelin antagonism in pulmonary hypertension, heart failure, and beyond.
    Attinà T; Camidge R; Newby DE; Webb DJ
    Heart; 2005 Jun; 91(6):825-31. PubMed ID: 15894792
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats.
    Emoto N; Raharjo SB; Isaka D; Masuda S; Adiarto S; Jeng AY; Yokoyama M
    Hypertension; 2005 Jun; 45(6):1145-52. PubMed ID: 15897363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic effects of an endothelin-converting enzyme inhibitor on cardiorenal and hormonal function in heart failure.
    Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Wang X; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():254S-257S. PubMed ID: 12193098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daglutril for treatment of renal damage in hypertensive patients with type 2 diabetes: disappointment or hope?
    Laurent S
    Lancet Diabetes Endocrinol; 2013 Sep; 1(1):2-3. PubMed ID: 24622251
    [No Abstract]   [Full Text] [Related]  

  • 20. Endothelin-1 in atherosclerosis and other vasculopathies.
    Bousette N; Giaid A
    Can J Physiol Pharmacol; 2003 Jun; 81(6):578-87. PubMed ID: 12839269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.